Mesoblast shares savaged on poor COVID trial results
MELBOURNE: Stem cell biotech Mesoblast has had its share price smashed after the company emerged
MELBOURNE: Stem cell biotech Mesoblast has had its share price smashed after the company emerged
FEATURED
New apartments are helping transform the treatment experience
Plan unveiled to replace former care home with 24 modern retirement flats
Modernist architecture now set to meet affordable housing for seniors
Land carve-ups help build better housing future for remote communities
Best retirement housing design for Global Awards shortlisted
Boomers high-rise set to come with a health hub
INNOVATION
